about
Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CCurrent status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cellsGenotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France.Genotyping of hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5' noncoding regionHepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV.Epidemiology of hepatitis C virus (HCV) infection.Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents.Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains.Risk factors of hepatitis C virus transmission and genotype distribution in former blood donors from Chinese rural area.Epidemiology and treatment of hepatitis C genotypes 5 and 6Assessment of commercial enzyme immunoassay for hepatitis C virus serotypingThe Role of MicroRNA in Hepatitis C Virus ReplicationEarly viral kinetics and response to treatment in a hepatitis C virus genotype 5 infected patient.Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.
P2860
Q26741123-FD6B761C-BE3D-46D5-8E43-9178D89B9AB1Q26828972-BF0A00C9-1199-4D2E-A79E-C3C4FB82C745Q27023059-E18AC6DA-8E43-42A2-8D61-37A56C1ED60AQ27471946-DFA73598-0164-42E2-B4D3-8017B769DD50Q27485754-1E7135F0-0DD1-4774-A984-499BEE9CCA87Q33874791-50EDA5B6-8EF3-4026-9870-91E4F36FD065Q33995067-CD1BEB4F-2512-4F99-B8BC-668943AC52C6Q34057584-855E1237-AC87-4694-AE9B-510D1B7131D4Q34533951-B08AA1FF-501D-4520-8BE9-A264231521CDQ35165283-0DAB374E-86B8-4FA0-A143-C5B0E8132EFBQ36534673-45CC6B97-403B-4D25-AF6C-78BD1031FC93Q37200946-25D452C7-8567-4A04-A978-ECC82C6D41A3Q38584077-632EC91D-FC1B-4AEF-A1F2-E9C1E64EED56Q38678972-91C81E35-35D3-4E1C-96AF-FF09290E361AQ42109722-B6808D35-C2E4-4E50-9A72-707A473FEF61Q42382462-17243FC4-5278-40C7-8713-3DD72CC5D4C3
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
Genotyping of hepatitis C virus in South Africa
@ast
Genotyping of hepatitis C virus in South Africa
@en
Genotyping of hepatitis C virus in South Africa
@nl
type
label
Genotyping of hepatitis C virus in South Africa
@ast
Genotyping of hepatitis C virus in South Africa
@en
Genotyping of hepatitis C virus in South Africa
@nl
prefLabel
Genotyping of hepatitis C virus in South Africa
@ast
Genotyping of hepatitis C virus in South Africa
@en
Genotyping of hepatitis C virus in South Africa
@nl
P2860
P3181
P1476
Genotyping of hepatitis C virus in South Africa
@en
P2093
Kannemeyer J
P2860
P304
P3181
P407
P577
1995-06-01T00:00:00Z